Atossa Therapeutics Inc’s recent filing unveils that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0 on May 21 ’25. In the deal valued at $0.88 per share,11,239 shares were bought. As a result of this transaction, QUAY STEVEN C now holds 13,898 shares worth roughly $11674.32.
Then, Remmel H. Lawrence bought 10,000 shares, generating $7,000 in total proceeds. Upon buying the shares at $0.70, the Director now owns 10,257 shares.
Maxim Group initiated its Atossa Therapeutics Inc [ATOS] rating to a Buy in a research note published on January 26, 2018; the price target was $2.
Price Performance Review of ATOS
On Friday, Atossa Therapeutics Inc [NASDAQ:ATOS] saw its stock fall -2.55% to $0.84. Over the last five days, the stock has lost -0.24%. Atossa Therapeutics Inc shares have fallen nearly -43.25% since the year began. Nevertheless, the stocks have fallen -11.04% over the past one year. While a 52-week high of $1.66 was reached on 05/14/25, a 52-week low of $0.55 was recorded on 04/07/25.
Levels Of Support And Resistance For ATOS Stock
The 24-hour chart illustrates a support level at 0.8102, which if violated will result in even more drops to 0.7804. On the upside, there is a resistance level at 0.8663. A further resistance level may holdings at 0.8926.
How much short interest is there in Atossa Therapeutics Inc?
A steep rise in short interest was recorded in Atossa Therapeutics Inc stocks on 2025-07-15, dropping by -3.33 million shares to a total of 4.09 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 7.42 million shares. There was a decline of -81.5%, which implies that there is a negative sentiment for the stock.
